Market reports project imaging equipment growth
Two recent market releases projected continued global growth for medical imaging equipment through the decade and flagged MRI demand in specific regions, citing major OEMs like GE HealthCare, Philips and Siemens. The releases were framed as investor‑oriented market forecasts rather than decision‑grade procurement signals. ( )
Medical imaging machines — the scanners hospitals use to look inside the body without surgery — are still drawing bullish growth forecasts through the end of the decade. Two April 2026 market releases projected continued expansion globally and in Middle East magnetic resonance imaging, or MRI, specifically. (openpr.com, openpr.com) The releases named General Electric HealthCare, Philips and Siemens among the companies tied to that outlook, but they were promotional summaries for paid market reports, not hospital purchasing data or government procurement records. OpenPR distributed both items in April 2026 as press-style market notices. (openpr.com, openpr.com) Medical imaging covers X-ray, computed tomography, ultrasound, magnetic resonance imaging and nuclear scans. Magnetic resonance imaging uses magnets and radio waves, not ionizing radiation, to produce detailed pictures of soft tissue such as the brain, spine and joints. (who.int, oecd.org) Independent market firms are also projecting growth, though the numbers vary. Grand View Research said the global medical imaging market was worth $43.5 billion in 2025 and could reach $64.7 billion by 2033, while Mordor Intelligence estimated the United States diagnostic imaging market at $10.57 billion in 2026 and $13.14 billion by 2031. (grandviewresearch.com, mordorintelligence.com) For the Middle East and Africa, Mordor Intelligence estimated the magnetic resonance imaging market at $426.33 million in 2026 and $548.8 million by 2031. That report also listed Philips, General Electric HealthCare and Siemens Healthineers among the major companies in the region. (mordorintelligence.com) The manufacturers cited in those forecasts are reporting real imaging business activity. General Electric HealthCare said 2025 revenue rose to $20.6 billion, with growth driven in part by Imaging and strength in the United States and Europe, Middle East and Africa. (gehealthcare.com) Philips reported 2025 group sales of 17.8 billion euros and said it published its 2025 annual report on February 19, 2026, ahead of its May 8, 2026 shareholder meeting. Philips’ investor materials frame imaging inside a broader diagnosis-and-treatment business rather than as a stand-alone public market tally. (philips.com, philips.com) The demand story is not just about investor models. The World Health Organization told its executive board in February 2025 that medical imaging is vital for diagnosing and treating communicable disease, noncommunicable disease and injuries, while access remains limited in many countries because of equipment costs, workforce shortages and weak policy support. (who.int) Capacity is uneven even in richer health systems. The Organisation for Economic Co-operation and Development tracks MRI units per million people across member countries, and the World Health Organization maintains a comparable equipment-density indicator for member states. (oecd.org, who.int) Software is also reshaping the equipment market. The U.S. Food and Drug Administration’s public list of artificial-intelligence-enabled medical devices shows imaging remains a major category for tools that help acquire, sort or interpret scans. (fda.gov) That leaves the April market releases in a narrow lane: useful as a read on investor pitch and industry sentiment, but not a substitute for tender data, installed-base counts or hospital budget decisions. The growth case for scanners is broad; the buying decisions are still local. (openpr.com, openpr.com)
